CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182958. A total of 5 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $573,000 | -83.4% | 47 | -79.1% | 0.02% | -83.6% |
| Q4 2020 | $3,445,000 | +83.0% | 225 | 0.0% | 0.13% | +12.3% |
| Q3 2020 | $1,882,000 | -17.4% | 225 | -27.4% | 0.11% | -26.9% |
| Q2 2020 | $2,279,000 | +73.4% | 310 | 0.0% | 0.16% | +43.1% |
| Q1 2020 | $1,314,000 | -4.1% | 310 | +37.8% | 0.11% | -8.4% |
| Q4 2019 | $1,370,000 | -52.7% | 225 | -68.2% | 0.12% | -55.3% |
| Q3 2019 | $2,898,000 | +173.4% | 707 | +214.2% | 0.27% | +177.1% |
| Q2 2019 | $1,060,000 | – | 225 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 225 | $3,445,000 | 0.13% |
| GROUP ONE TRADING, L.P. | 355,400 | $54,415,000 | 0.09% |
| Marathon Trading Investment Management LLC | 3,400 | $521,000 | 0.03% |
| SIMPLEX TRADING, LLC | 413 | $6,323,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |